ONCT
Oncternal Therapeutics, Inc. Common Stock
ONCT
ONCT
Delisted
ONCT was delisted on the 2nd of December, 2024.
23 hedge funds and large institutions have $4.03M invested in Oncternal Therapeutics, Inc. Common Stock in 2020 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 7 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
23
Holders Change
+2
Holders Change %
+9.52%
% of All Funds
0.51%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
5
Reduced
7
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
IC
IEQ Capital
Foster City,
California
|
+$212K |
| 2 |
DY
Dowling & Yahnke
San Diego,
California
|
+$73.7K |
| 3 |
Creative Planning
Overland Park,
Kansas
|
+$30.2K |
| 4 |
UCFA
United Capital Financial Advisors
Irving,
Texas
|
+$20.8K |
| 5 |
Renaissance Technologies
New York
|
+$18.6K |
Top Sellers
| 1 |
Bank of America
Charlotte,
North Carolina
|
-$15.1K |
| 2 |
Millennium Management
New York
|
-$8.43K |
| 3 |
ACM
Anfield Capital Management
Irvine,
California
|
-$8K |
| 4 |
Morgan Stanley
New York
|
-$2.83K |
| 5 |
NSIM
North Star Investment Management
Chicago,
Illinois
|
-$2.7K |
